BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Middeldorp JM, Brink AA, van den Brule AJ, Meijer CJ. Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Crit Rev Oncol Hematol. 2003;45:1-36. [PMID: 12482570 DOI: 10.1016/S1040-8428(02)00078-1] [Cited by in Crossref: 116] [Cited by in F6Publishing: 59] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Aboulkassim T, Yasmeen A, Akil N, Batist G, Al Moustafa AE. Incidence of Epstein-Barr virus in Syrian women with breast cancer: A tissue microarray study. Hum Vaccin Immunother 2015;11:951-5. [PMID: 25933186 DOI: 10.1080/21645515.2015.1009342] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
2 Younesi V, Shirazi FG, Memarian A, Amanzadeh A, Jeddi-Tehrani M, Shokri F. Assessment of the effect of TLR7/8, TLR9 agonists and CD40 ligand on the transformation efficiency of Epstein-Barr virus in human B lymphocytes by limiting dilution assay. Cytotechnology 2014;66:95-105. [PMID: 23404520 DOI: 10.1007/s10616-013-9542-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
3 Meier UC, Cipian RC, Karimi A, Ramasamy R, Middeldorp JM. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis. Front Immunol 2021;12:757302. [PMID: 34790199 DOI: 10.3389/fimmu.2021.757302] [Reference Citation Analysis]
4 He B, Li W, Wu Y, Wei F, Gong Z, Bo H, Wang Y, Li X, Xiang B, Guo C, Liao Q, Chen P, Zu X, Zhou M, Ma J, Li X, Li Y, Li G, Xiong W, Zeng Z. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103. Cell Death Dis 2016;7:e2353. [PMID: 27584792 DOI: 10.1038/cddis.2016.253] [Cited by in Crossref: 78] [Cited by in F6Publishing: 94] [Article Influence: 13.0] [Reference Citation Analysis]
5 Kim DN, Song YJ, Lee SK. The role of promoter methylation in Epstein-Barr virus (EBV) microRNA expression in EBV-infected B cell lines. Exp Mol Med 2011;43:401-10. [PMID: 21628990 DOI: 10.3858/emm.2011.43.7.044] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
6 Kim DN, Lee SK. Biogenesis of Epstein-Barr virus microRNAs. Mol Cell Biochem 2012;365:203-10. [PMID: 22350759 DOI: 10.1007/s11010-012-1261-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
7 Hutajulu SH, Fachiroh J, Argy G, Indrasari SR, Indrawati LPL, Paramita DK, Jati TBR, Middeldorp JM. Seroprevalence of IgA anti Epstein-Barr virus is high among family members of nasopharyngeal cancer patients and individuals presenting with chronic complaints in head and neck area. PLoS One 2017;12:e0180683. [PMID: 28800616 DOI: 10.1371/journal.pone.0180683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 Holm A, Schindele A, Allard A, Eriksson I, Sandström K, Laurell G, Nylander K, Olofsson K. Mapping of human papilloma virus, p16, and epstein-barr virus in non-malignant tonsillar disease. Laryngoscope Investig Otolaryngol 2019;4:285-91. [PMID: 31236460 DOI: 10.1002/lio2.260] [Reference Citation Analysis]
9 Park GB, Kim YS, Song H, Kim S, Park DM, Lee WJ, Hur DY. Cross-linking of CD80 and CD86 Diminishes Expression of CD54 on EBV-transformed B Cells through Inactivation of RhoA and Ras. Immune Netw 2011;11:390-8. [PMID: 22346780 DOI: 10.4110/in.2011.11.6.390] [Reference Citation Analysis]
10 Cyprian FS, Al-Farsi HF, Vranic S, Akhtar S, Al Moustafa AE. Epstein-Barr Virus and Human Papillomaviruses Interactions and Their Roles in the Initiation of Epithelial-Mesenchymal Transition and Cancer Progression. Front Oncol 2018;8:111. [PMID: 29765906 DOI: 10.3389/fonc.2018.00111] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
11 Liu X, Tang J, Wang M, Ma Q, Wang Y. Visual detection and evaluation of latent and lytic gene expression during Epstein-Barr virus infection using one-step reverse transcription loop-mediated isothermal amplification. Int J Mol Sci 2013;14:23922-40. [PMID: 24351866 DOI: 10.3390/ijms141223922] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
12 Rosenkilde MM, Smit MJ, Waldhoer M. Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors. Br J Pharmacol 2008;153 Suppl 1:S154-66. [PMID: 18204488 DOI: 10.1038/sj.bjp.0707660] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
13 Budiningsih I, Dachlan YP, Hadi U, Middeldorp JM, Carvalho LH. Quantitative cytokine level of TNF-α, IFN-γ, IL-10, TGF-β and circulating Epstein-Barr virus DNA load in individuals with acute Malaria due to P. falciparum or P. vivax or double infection in a Malaria endemic region in Indonesia. PLoS ONE 2021;16:e0261923. [DOI: 10.1371/journal.pone.0261923] [Reference Citation Analysis]
14 Ok CY, Li L, Young KH. EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management. Exp Mol Med. 2015;47:e132. [PMID: 25613729 DOI: 10.1038/emm.2014.82] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 9.4] [Reference Citation Analysis]
15 Jha HC, Pei Y, Robertson ES. Epstein-Barr Virus: Diseases Linked to Infection and Transformation. Front Microbiol 2016;7:1602. [PMID: 27826287 DOI: 10.3389/fmicb.2016.01602] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
16 Cai Y, Song Y, Cen D, Zhang C, Mao S, Ye X, Xiong Y, Jiang P, Chen J, Xue X, Zhang L, Zhu G. Novel ELISA for serodiagnosis of nasopharyngeal carcinoma based on a B cell epitope of Epstein-Barr virus latent membrane protein 2. Oncol Lett 2018;16:4372-8. [PMID: 30214572 DOI: 10.3892/ol.2018.9216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo S, Tan IB, Middeldorp JM. Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer 2012;31:185-96. [PMID: 22313595 DOI: 10.5732/cjc.011.10328] [Cited by in Crossref: 105] [Cited by in F6Publishing: 87] [Article Influence: 10.5] [Reference Citation Analysis]
18 Choi H, Lee H, Kim SR, Gho YS, Lee SK. Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. J Virol 2013;87:8135-44. [PMID: 23678170 DOI: 10.1128/JVI.03159-12] [Cited by in Crossref: 72] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
19 Huang SH, Kozak PJ, Kim J, Habineza-Ndikuyeze G, Meade C, Gaurnier-Hausser A, Patel R, Robertson E, Mason NJ. Evidence of an oncogenic gammaherpesvirus in domestic dogs. Virology 2012;427:107-17. [PMID: 22405628 DOI: 10.1016/j.virol.2012.02.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
20 Tang W, Harmon P, Gulley ML, Mwansambo C, Kazembe PN, Martinson F, Wokocha C, Kenney SC, Hoffman I, Sigel C, Maygarden S, Hoffman M, Shores C. Viral response to chemotherapy in endemic burkitt lymphoma. Clin Cancer Res 2010;16:2055-64. [PMID: 20233888 DOI: 10.1158/1078-0432.CCR-09-2424] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
21 He YJ, Bai GH, Guo YD. Correlation between Epstein-Barr virus infection and tumor angiogenesis in patients with gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2011; 19(30): 3172-3176 [DOI: 10.11569/wcjd.v19.i30.3172] [Reference Citation Analysis]
22 Hoebe EK, Wille C, Hopmans ES, Robinson AR, Middeldorp JM, Kenney SC, Greijer AE. Epstein-Barr virus transcription activator R upregulates BARF1 expression by direct binding to its promoter, independent of methylation. J Virol 2012;86:11322-32. [PMID: 22896599 DOI: 10.1128/JVI.01161-12] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
23 Hutajulu SH, Hoebe EK, Verkuijlen SA, Fachiroh J, Hariwijanto B, Haryana SM, Stevens SJ, Greijer AE, Middeldorp JM. Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma. Infect Agent Cancer 2010;5:16. [PMID: 20849661 DOI: 10.1186/1750-9378-5-16] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
24 Lassmann H, Niedobitek G, Aloisi F, Middeldorp JM; NeuroproMiSe EBV Working Group. Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 2011;134:2772-86. [PMID: 21846731 DOI: 10.1093/brain/awr197] [Cited by in Crossref: 121] [Cited by in F6Publishing: 105] [Article Influence: 11.0] [Reference Citation Analysis]
25 Greijer AE, Stevens SJ, Verkuijlen SA, Juwana H, Fleig SC, Verschuuren EA, Hepkema BG, Cornelissen JJ, Brooimans RA, Verdonck LF, Middeldorp JM. Variable EBV DNA load distributions and heterogeneous EBV mRNA expression patterns in the circulation of solid organ versus stem cell transplant recipients. Clin Dev Immunol 2012;2012:543085. [PMID: 23346186 DOI: 10.1155/2012/543085] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
26 Al-Antary N, Farghaly H, Aboulkassim T, Yasmeen A, Akil N, Al Moustafa AE. Epstein-Barr virus and its association with Fascin expression in colorectal cancers in the Syrian population: A tissue microarray study. Hum Vaccin Immunother 2017;13:1573-8. [PMID: 28350509 DOI: 10.1080/21645515.2017.1302046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
27 Le Clorennec C, Ouk TS, Youlyouz-Marfak I, Panteix S, Martin CC, Rastelli J, Adriaenssens E, Zimber-Strobl U, Coll J, Feuillard J, Jayat-Vignoles C. Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis. J Virol 2008;82:6721-33. [PMID: 18448526 DOI: 10.1128/JVI.02250-07] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
28 Gupta D, Mendonca S, Chakraborty S, Chatterjee T. Post Transplant Lymphoproliferative Disorder. Indian J Hematol Blood Transfus 2020;36:229-37. [PMID: 32425371 DOI: 10.1007/s12288-019-01182-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Kawabe S, Ito Y, Gotoh K, Kojima S, Matsumoto K, Kinoshita T, Iwata S, Nishiyama Y, Kimura H. Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases. Cancer Sci 2012;103:1481-8. [PMID: 22497716 DOI: 10.1111/j.1349-7006.2012.02305.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
30 Hoebe EK, Hutajulu SH, van Beek J, Stevens SJ, Paramita DK, Greijer AE, Middeldorp JM. Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients. Clin Vaccine Immunol 2011;18:298-304. [PMID: 21123521 DOI: 10.1128/CVI.00193-10] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
31 Akhtar S, Vranic S, Cyprian FS, Al Moustafa AE. Epstein-Barr Virus in Gliomas: Cause, Association, or Artifact? Front Oncol 2018;8:123. [PMID: 29732319 DOI: 10.3389/fonc.2018.00123] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
32 Grossman L, Chang C, Dai J, Nikitin PA, Jima DD, Dave SS, Luftig MA. Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines. mSphere 2017;2:e00305-17. [PMID: 29202043 DOI: 10.1128/mSphere.00305-17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
33 Nagi K, Gupta I, Jurdi N, Yasmeen A, Vranic S, Batist G, Moustafa AA. Copresence of High-Risk Human Papillomaviruses and Epstein-Barr Virus in Colorectal Cancer: A Tissue Microarray and Molecular Study from Lebanon. Int J Mol Sci 2021;22:8118. [PMID: 34360884 DOI: 10.3390/ijms22158118] [Reference Citation Analysis]
34 Balvedi RP, Castro AC, Madurro JM, Brito-Madurro AG. Detection of a specific biomarker for Epstein-Barr virus using a polymer-based genosensor. Int J Mol Sci 2014;15:9051-66. [PMID: 24853286 DOI: 10.3390/ijms15059051] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
35 Casabonne D, Benavente Y, Robles C, Costas L, Alonso E, Gonzalez-Barca E, Tardón A, Dierssen-Sotos T, Vázquez EG, Aymerich M, Campo E, Castaño-Vinyals G, Aragones N, Pollan M, Kogevinas M, Juwana H, Middeldorp J, de Sanjose S. Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study. Infect Agent Cancer 2015;10:5. [PMID: 25972916 DOI: 10.1186/1750-9378-10-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Chen X, Liang S, Zheng W, Liao Z, Shang T, Ma W. Meta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformation. BMC Genomics 2008;9:322. [PMID: 18605998 DOI: 10.1186/1471-2164-9-322] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
37 Pei Y, Singh RK, Shukla SK, Lang F, Zhang S, Robertson ES. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2. J Virol 2018;92:e00663-18. [PMID: 29997218 DOI: 10.1128/JVI.00663-18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
38 Midoen YH, Suryandari DA, Yunaini L, Susworo R, Auerkari EI, Freisleben HJ. Epstein-Barr virus nuclear antigen-1 is useful as therapeutic efficacy marker in serum but not in saliva of nasopharyngeal cancer patients who underwent radiotherapy. Ecancermedicalscience 2021;15:1254. [PMID: 34267810 DOI: 10.3332/ecancer.2021.1254] [Reference Citation Analysis]
39 Kim H, Iizasa H, Kanehiro Y, Fekadu S, Yoshiyama H. Herpesviral microRNAs in Cellular Metabolism and Immune Responses. Front Microbiol 2017;8:1318. [PMID: 28769892 DOI: 10.3389/fmicb.2017.01318] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
40 Hoebe EK, Le Large TY, Greijer AE, Middeldorp JM. BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator. Rev Med Virol 2013;23:367-83. [PMID: 23996634 DOI: 10.1002/rmv.1758] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
41 Pegoraro F, Favre C. Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation. Ann Hematol 2021;100:865-78. [PMID: 33547921 DOI: 10.1007/s00277-021-04433-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, Kusumo H, Zeng YS, Schouten T, Mubarika S, Middeldorp JM. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening. J Clin Microbiol 2006;44:1459-67. [PMID: 16597877 DOI: 10.1128/JCM.44.4.1459-1467.2006] [Cited by in Crossref: 85] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
43 Jha HC, Mehta D, Lu J, El-Naccache D, Shukla SK, Kovacsics C, Kolson D, Robertson ES. Gammaherpesvirus Infection of Human Neuronal Cells. mBio 2015;6:e01844-15. [PMID: 26628726 DOI: 10.1128/mBio.01844-15] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
44 Delbende C, Verwaerde C, Mougel A, Tranchand Bunel D. Induction of therapeutic antibodies by vaccination against external loops of tumor-associated viral latent membrane protein. J Virol 2009;83:11734-45. [PMID: 19726497 DOI: 10.1128/JVI.00578-09] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
45 Saha A, Robertson ES. Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes. Clin Cancer Res. 2011;17:3056-3063. [PMID: 21372216 DOI: 10.1158/1078-0432.ccr-10-2578] [Cited by in Crossref: 103] [Cited by in F6Publishing: 62] [Article Influence: 9.4] [Reference Citation Analysis]
46 Paydas S. Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacity. Med Oncol 2012;29:2159-65. [PMID: 21948392 DOI: 10.1007/s12032-011-0065-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
47 Truong CD, Feng W, Li W, Khoury T, Li Q, Alrawi S, Yu Y, Xie K, Yao J, Tan D. Characteristics of Epstein-Barr virus-associated gastric cancer: a study of 235 cases at a comprehensive cancer center in U.S.A. J Exp Clin Cancer Res 2009;28:14. [PMID: 19192297 DOI: 10.1186/1756-9966-28-14] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
48 Hutajulu SH, Kurnianda J, Tan IB, Middeldorp JM. Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma. Ther Clin Risk Manag 2014;10:721-36. [PMID: 25228810 DOI: 10.2147/TCRM.S47434] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
49 Ahangarani RR, Janssens W, Carlier V, Vanderelst L, Vandendriessche T, Chuah M, Jacquemin M, Saint-Remy JM. Retroviral vectors induce epigenetic chromatin modifications and IL-10 production in transduced B cells via activation of toll-like receptor 2. Mol Ther 2011;19:711-22. [PMID: 21157434 DOI: 10.1038/mt.2010.275] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
50 Zhang W, Chen B, Chen Y, Chamberland R, Fider-Whyte A, Craig J, Varma C, Befeler AS, Bisceglie AM, Horton P, Lai JP. Epstein-Barr Virus-Associated Acute Liver Failure Present in a 67-Year-Old Immunocompetent Female. Gastroenterology Res 2016;9:74-8. [PMID: 27785330 DOI: 10.14740/gr718e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
51 He B, Tran JT, Sanchez DJ. Manipulation of Type I Interferon Signaling by HIV and AIDS-Associated Viruses. J Immunol Res 2019;2019:8685312. [PMID: 31089479 DOI: 10.1155/2019/8685312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
52 Al-Thawadi H, Gupta I, Jabeen A, Skenderi F, Aboulkassim T, Yasmeen A, Malki MI, Batist G, Vranic S, Al Moustafa AE. Co-presence of human papillomaviruses and Epstein-Barr virus is linked with advanced tumor stage: a tissue microarray study in head and neck cancer patients. Cancer Cell Int 2020;20:361. [PMID: 32774155 DOI: 10.1186/s12935-020-01348-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
53 Sitompul LS, Widodo N, Djati MS, Utomo DH. Epitope mapping of gp350/220 conserved domain of epstein barr virus to develop nasopharyngeal carcinoma (npc) vaccine. Bioinformation 2012;8:479-82. [PMID: 22715303 DOI: 10.6026/97320630008479] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
54 Gupta I, Ghabreau L, Al-Thawadi H, Yasmeen A, Vranic S, Al Moustafa AE, Malki MI. Co-incidence of Human Papillomaviruses and Epstein-Barr Virus Is Associated With High to Intermediate Tumor Grade in Human Head and Neck Cancer in Syria. Front Oncol 2020;10:1016. [PMID: 32974123 DOI: 10.3389/fonc.2020.01016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
55 Zur Hausen A, van Rees BP, van Beek J, Craanen ME, Bloemena E, Offerhaus GJ, Meijer CJ, van den Brule AJ. Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis. J Clin Pathol. 2004;57:487-491. [PMID: 15113855 DOI: 10.1136/jcp.2003.014068] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 2.4] [Reference Citation Analysis]
56 Segarra A, Baillon L, Tourbiez D, Benabdelmouna A, Faury N, Bourgougnon N, Renault T. Ostreid herpesvirus type 1 replication and host response in adult Pacific oysters, Crassostrea gigas. Vet Res 2014;45:103. [PMID: 25294338 DOI: 10.1186/s13567-014-0103-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
57 Hur DY, Lee MH, Kim JW, Kim JH, Shin YK, Rho JK, Kwack KB, Lee WJ, Han BG. CD19 signalling improves the Epstein-Barr virus-induced immortalization of human B cell. Cell Prolif 2005;38:35-45. [PMID: 15679865 DOI: 10.1111/j.1365-2184.2005.00328.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
58 Farhat M, Poissonnier A, Hamze A, Ouk-Martin C, Brion JD, Alami M, Feuillard J, Jayat-Vignoles C. Reversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to spindle poisons by exogenous activation of JNK and p38 MAP kinases. Cell Death Dis 2014;5:e1201. [PMID: 24787013 DOI: 10.1038/cddis.2014.150] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
59 Stevens SJ, Verkuijlen SA, Hariwiyanto B, Harijadi, Fachiroh J, Paramita DK, Tan IB, Haryana SM, Middeldorp JM. Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia. J Clin Microbiol 2005;43:3066-73. [PMID: 16002393 DOI: 10.1128/JCM.43.7.3066-3073.2005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
60 Hoebe E, Wille C, Hagemeier S, Kenney S, Greijer A, Middeldorp J. Epstein-Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma. Cancers (Basel) 2018;10:E76. [PMID: 29562599 DOI: 10.3390/cancers10030076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
61 Marques M, Luz E, Hummel M, Vieira Md, Bahia RC, Oliveira MC, Netto EM, Luz I, Araújo I. Prognostic Biomarkers and EBV Infection Research in Diffuse Large B-Cell Lymphoma of the Palatine Tonsils. ISRN Oncol 2012;2012:652682. [PMID: 22518331 DOI: 10.5402/2012/652682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
62 Savitri E, Haryana MS. Expression of interleukin-8, interleukin-10 and Epstein-Barr viral-load as prognostic indicator in nasopharyngeal carcinoma. Glob J Health Sci 2015;7:364-72. [PMID: 25948470 DOI: 10.5539/gjhs.v7n3p364] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]